Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 15, Issue 19, pp. 6250-6257
PubMed
Published By
Print ISSN
Online ISSN
History
- Received January 19, 2009
- Revision received May 22, 2009
- Accepted June 22, 2009
- Published first September 22, 2009.
Article Versions
- Previous version (September 22, 2009 - 07:52).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2009 American Association for Cancer Research.
Author Information
- Michael L. Maitland1,2,3,
- Kristen E. Kasza4,
- Theodore Karrison3,4,
- Kristin Moshier6,
- Laura Sit1,
- Henry R. Black7,
- Samir D. Undevia1,
- Walter M. Stadler1,3,
- William J. Elliott5 and
- Mark J. Ratain1,2,3
- Authors' Affiliations: 1Section of Hematology/Oncology, Department of Medicine; 2Committee on Clinical Pharmacology and Pharmacogenomics; 3Cancer Research Center; and 4Department of Health Studies, University of Chicago; 5Department of Preventive Medicine, Rush University Medical Center, Chicago, Illinois; 6Kansas University Medical Center, Kansas City, Kansas; and 7Division of Nephrology and Hypertension, Department of Medicine, New York University School of Medicine, New York, New York
- Requests for reprints:
Michael L. Maitland, 5841 South Maryland Avenue, MC-2115, Section of Hematology/Oncology, Department of Medicine, Chicago, IL 60637. Phone: 773-834-8981; Fax: 773-834-0188; E-mail: mmaitlan{at}medicine.bsd.uchicago.edu.
October 2009
Volume 15, Issue 19
Volume 15, Issue 19
Ambulatory Monitoring Detects Sorafenib-Induced Blood Pressure Elevations on the First Day of Treatment
Jump to section
Advertisement